Investor FAQs - Palvella Therapeutics

Where is Palvella Therapeutics headquartered?

125 Strafford Avenue, Suite 360, Wayne, PA 19087

Where is Palvella Therapeutics incorporated?

Palvella Therapeutics is incorporated in Delaware.

When was Palvella Therapeutics founded?

Palvella Therapeutics was founded in 2015.

When did Palvella Therapeutics’ merger close?

Palvella Therapeutics completed a merger with Pieris Pharmaceuticals, Inc. and began trading in December 2024.

Which stock exchange are Palvella Therapeutics shares traded on and what is the company’s ticker?

Palvella Therapeutics’ shares are traded on the Nasdaq Capital Market under the symbol PVLA.

When does Palvella Therapeutics’ fiscal year end?

Palvella Therapeutics’ fiscal year ends on December 31.

Who is Palvella Therapeutics’ transfer agent?

Computershare, P.O. Box 43006, Providence, RI 02940-3078

Who is Palvella Therapeutics’ legal counsel?

Troutman Pepper Hamilton Sanders LLP

Who is Palvella Therapeutics’ independent auditor?

Ernst & Young LLP

What is Palvella Therapeutics’ CUSIP number?

697947109

How can I purchase Palvella Therapeutics shares?

Shares of Palvella Therapeutics’ stock can be purchased by contacting a securities broker of your choice.

Does Palvella Therapeutics pay dividends and have a dividend reinvestment program?

Palvella Therapeutics does not currently pay dividends or offer a dividend reinvestment program.

Where can I get additional information on Contingent Value Rights (CVRs) related to the merger with Pieris Pharmaceuticals, Inc.?

Information related to CVRs can be found in SEC filings and can be accessed at www.sec.gov. The original CVR Agreement can be found directly on the SEC website at this link.

Whom do I contact with questions about my stock (transfer stock, change the address on my shareholder account, or replace a lost stock certificate)?

For questions about your stock please contact our transfer agent, Computershare.

How can I view documents Palvella Therapeutics has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?

Quarterly & Annual reports and other investor materials are available in the “Investors” section of Palvella Therapeutics’s corporate website. Additionally, all SEC filings can also be accessed directly from the SEC at www.sec.gov.

How can I sign up to receive Palvella Therapeutics press releases and other company information?

Please click here to be directed to the email alerts page.

Whom should I contact if I am a member of the media?

For media inquiries, please send an email to palvella@argotpartners.com.

Whom should I contact if I have additional questions?

For investor inquiries, please send an email to palvella@argotpartners.com.